ClinicalTrials.Veeva

Menu

Association of Hb F Level With Clinical Severity of Beta Thalassemia

N

Nanfang Hospital, Southern Medical University

Status

Enrolling

Conditions

Beta Thalassemia

Treatments

Diagnostic Test: Hematological Phenotype Analysis

Study type

Observational

Funder types

Other

Identifiers

NCT04917978
HbF-Beta thalassemia

Details and patient eligibility

About

The production of Hb F after birth is an important factor in modifying the clinical severity of beta thalassemia because an increased gamma-globin level will bind the additional a-globin and form Hb F. The objective of this project is to evaluate the association of Hb F level with phenotypic diversity of patients with beta thalassemia.

Enrollment

1,200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with beta-thalassemia

Exclusion criteria

  • Iron Deficiency Anemia

Trial design

1,200 participants in 1 patient group

beta thalassemia patients
Treatment:
Diagnostic Test: Hematological Phenotype Analysis

Trial contacts and locations

1

Loading...

Central trial contact

Xiangmin Xu, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems